Research graph
References from Accuracy of Water Intake During Simulated Administration of Oral Semaglutide. Local targets link to admitted publications; unresolved targets remain external evidence.
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
10.1007/s40265-021-01499-w · 2021 · External reference
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon‐Like Peptide‐1 Analogue in a Tablet Formulation
10.1007/s13300-021-01078-y · 2021 · External reference
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial
10.1001/jama.2017.14752 · 2017 · External reference
Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach
10.1111/dom.70769 · 2026 · External reference
A Study on Accuracy and Precision of Fluid Volume Measurements by Nurses, Patients and Healthy Persons in a Clinical Setting
10.1002/nop2.1173 · 2022 · External reference
Novel GLP‐1‐Based Medications for Type 2 Diabetes and Obesity
10.1210/endrev/bnaf036 · 2026 · External reference
Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight
10.1111/dom.70783 · 2026 · External reference
